Substance / Medication

Adenosine phosphate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Diagnostic Test Accuracy of Exercise Testing in Detecting High-Risk Accessory Pathways in WPW: A Systematic Review and Meta-Analysis.
Alencar José Nunes de, Rassi Fabio Mahamad, Rios Raquel Pereira et al. · Arq Bras Cardiol · 2025
PMID: 40367005Meta-AnalysisFull text (PMC)
Risk of arrhythmia and sudden death in patients with asymptomatic preexcitation: a meta-analysis.
Obeyesekere Manoj N, Leong-Sit Peter, Massel David et al. · Circulation · 2012
PMID: 22532593Meta-Analysis
Incidence of atrial fibrillation and prevalence of intermittent pre-excitation in asymptomatic Wolff-Parkinson-White patients: a meta-analysis.
Obeyesekere Manoj N, Leong-Sit Peter, Massel David et al. · Int J Cardiol · 2012
PMID: 22694779Meta-Analysis
Ventricular versus atrial side ablation for treatment of atrioventricular accessory pathways: a randomized controlled clinical trial.
Nikoo Mohammad Hossein, Khorshidifar Meghdad, Nasrollahi Elham et al. · J Interv Card Electrophysiol · 2022
PMID: 35013893RCT
The advantage of the mini-electrode-equipped catheter for the radiofrequency ablation of paroxysmal supraventricular tachycardia.
Choi Young, Kim Sung-Hwan, Kim Hwajung et al. · J Cardiovasc Electrophysiol · 2022
PMID: 35924472RCT
Electrophysiological effects of desflurane in children with Wolff-Parkinson-White syndrome: a randomized crossover study.
Hino H, Oda Y, Yoshida Y et al. · Acta Anaesthesiol Scand · 2018
PMID: 29068040RCT
Prophylactic accessory-pathway ablation in asymptomatic patients with a Wolff-Parkinson-White electrocardiographic pattern.
Ozenc S, Iscen S, Kibrisli E et al. · Eur Rev Med Pharmacol Sci · 2014
PMID: 24763877RCT
High-dose remifentanil suppresses sinoatrial conduction and sinus node automaticity in pediatric patients under propofol-based anesthesia.
Fujii Keisuke, Iranami Hiroshi, Nakamura Yoshihide et al. · Anesth Analg · 2011
PMID: 21346159RCT
Wolff-Parkinson-White syndrome and atrioventricular nodal re-entry tachycardia in a Swedish population: consequences on health-related quality of life.
Walfridsson Ulla, Strömberg Anna, Janzon Magnus et al. · Pacing Clin Electrophysiol · 2009
PMID: 19702600RCT
Electrophysiologic characteristics and radiofrequency catheter ablation in children with Wolff-Parkinson-White syndrome.
Lee Pi-Chang, Hwang Betau, Chen Yi-Jen et al. · Pacing Clin Electrophysiol · 2006
PMID: 16689844RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Adenosine phosphate (substance)
SNOMED CT
54941006
UMLS CUI
C0001465

Clinical Data

This intervention maps to 3 entities in the Ltrl knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.